Also trades as: DRMA (NASDAQ) · $vol 2M
DRMAW NASDAQ
Dermata Therapeutics, Inc.
1W: +27.1%
1M: +0.0%
3M: -5.7%
YTD: -1.2%
1Y: +98.9%
$0.01
-0.00 (-9.35%)
Weekly Expected Move ±38.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-03-26
EPS
$-0.35
▲ Beat +77.3%
Revenue
—
Next Earnings
2026-08-18
EPS Estimate
$-0.55
Range: $-0.55 - $-0.55
Estimate vs Actual
Earnings Surprise History
3/7
EPS Beats
0/7
Revenue Beats
43%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | quarter | 2026-12-31 | $-0.50 | $-0.56 | ▼ 0.06 | $75,000 | $75,000 |
| 2026-05-19 | quarter | 2026-09-30 | $-0.61 | $-0.63 | ▼ 0.02 | $25,000 | $25,000 |
| 2026-05-19 | quarter | 2026-06-30 | $-0.57 | $-0.55 | ▲ 0.02 | $— | $— |
| 2026-04-08 | quarter | 2026-12-31 | $-0.65 | $-0.50 | ▲ 0.15 | $— | $75,000 |
| 2026-04-08 | quarter | 2026-06-30 | $-0.84 | $-0.57 | ▲ 0.27 | $— | $— |
| 2026-04-08 | quarter | 2026-09-30 | $-0.84 | $-0.61 | ▲ 0.23 | $— | $25,000 |
| 2026-04-08 | annual | 2027-12-31 | $— | $-1.49 | ▼ 1.49 | $750,000 | $750,000 |
| 2026-04-08 | quarter | 2026-03-31 | $-0.72 | $-0.53 | ▲ 0.19 | $— | $— |
| 2026-04-08 | annual | 2026-12-31 | $-3.01 | $-2.20 | ▲ 0.81 | $15,000,000 | $100,000 |
| 2026-04-06 | annual | 2027-12-31 | $— | $— | — | $750 | $750,000 |
| 2026-04-03 | annual | 2027-12-31 | $— | $— | — | $— | $750 |
| 2026-03-30 | quarter | 2026-12-31 | $— | $-0.65 | ▼ 0.65 | $— | $— |
| 2026-03-30 | quarter | 2026-03-31 | $— | $-0.72 | ▼ 0.72 | $— | $— |
| 2026-03-30 | quarter | 2025-12-31 | $— | $-1.54 | ▼ 1.54 | $— | $— |
Earnings Call Transcripts
No transcripts available.